Skip to main content

23andMe to Be Bought by Biotech Company for $256 Million

23andMe to Be Bought by Biotech Company for $256 Million
By Michael Levenson from NYT Business https://ift.tt/i68KZqT
Bankruptcies, Mergers, Acquisitions and Divestitures, Genetics and Heredity, Privacy, 23andMe, Regeneron Pharmaceuticals Inc, Bonta, Rob (1972- ), Wojcicki, Anne, Yancopoulos, George D, Tarrytown (NY), DNA (Deoxyribonucleic Acid)

Comments

Popular posts from this blog

Best of 2023: Will ChatGPT Replace Developers?

As we close out 2023, we at DevOps.com wanted to highlight the most popular articles of the year. Following is the latest in our series of the Best of 2023. AI is buzzing again thanks to the recent release of ChatGPT, a natural language chatbot that people are using to write emails, poems, song lyrics […] from DevOps.com https://ift.tt/Cy42I8D